Guardant Health
GH
#1108
Rank
NZ$38.61 B
Marketcap
NZ$285.41
Share price
2.34%
Change (1 day)
65.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company